menu search

Top- and bottom-line beat gives regeneron stock a boost

Regeneron pharmaceuticals Inc (NASDAQ:REGN) is up 1.9% to trade at $632.42 at last check, after the dr...

February 4, 2022, 10:26 am

Bristol-myers q4 results are out: this is what the report tells us

Shares of Bristol-Myers Squibb Co (NYSE: BMY) jumped 3.0% on Friday morning after the pharmaceutical gi...

February 4, 2022, 10:08 am

Bristol-myers q4 results are out: this is what the report tells us

Shares of Bristol-Myers Squibb Co (NYSE: BMY) jumped 3.0% on Friday morning after the pharmaceutical gi...

February 4, 2022, 10:08 am

Bristol-myers q4 results are out: this is what the report tells us

Shares of Bristol-Myers Squibb Co (NYSE: BMY) jumped 3.0% on Friday morning after the pharmaceutical gi...

February 4, 2022, 10:08 am

Why are vanda pharma shares plunging today?

Vanda pharmaceuticals Inc  VNDA shares are plunging after the company announced Phase 3 trial data of ...

February 4, 2022, 8:34 am

Why are vanda pharma shares plunging today?

Vanda pharmaceuticals Inc  VNDA shares are plunging after the company announced Phase 3 trial data of ...

February 4, 2022, 8:34 am

Why are vanda pharma shares plunging today?

Vanda pharmaceuticals Inc  VNDA shares are plunging after the company announced Phase 3 trial data of ...

February 4, 2022, 8:34 am

Regeneron's q4 sales, profits more than double with boost from covid-19 treatment sales

Regeneron pharmaceuticals Inc  REGN earned $23.72 per share for Q4 FY21, more than double from $9.53 ...

February 4, 2022, 8:01 am

Regeneron's q4 sales, profits more than double with boost from covid-19 treatment sales

Regeneron pharmaceuticals Inc  REGN earned $23.72 per share for Q4 FY21, more than double from $9.53 ...

February 4, 2022, 8:01 am

Regeneron's q4 sales, profits more than double with boost from covid-19 treatment sales

Regeneron pharmaceuticals Inc  REGN earned $23.72 per share for Q4 FY21, more than double from $9.53 ...

February 4, 2022, 8:01 am

Algernon pharmaceuticals completes enrollment in its phase 2 study of ifenprodil for ipf and chronic cough

Algernon pharmaceuticals Inc said it has completed enrollment in a Phase 2 study for its repurposed dru...

February 4, 2022, 7:57 am

Algernon pharmaceuticals completes enrollment in its phase 2 study of ifenprodil for ipf and chronic cough

Algernon pharmaceuticals Inc said it has completed enrollment in a Phase 2 study for its repurposed dru...

February 4, 2022, 7:57 am

Algernon pharmaceuticals completes enrollment in its phase 2 study of ifenprodil for ipf and chronic cough

Algernon pharmaceuticals Inc said it has completed enrollment in a Phase 2 study for its repurposed dru...

February 4, 2022, 7:57 am

Nyse-listed pharma co. dr. reddy's to acquire german medical cannabis firm nimbus health gmbh

pharmaceutical company Dr. Reddy's Laboratories Ltd. RDY has entered into a definitive agreement to acq...

February 4, 2022, 7:37 am

Nyse-listed pharma co. dr. reddy's to acquire german medical cannabis firm nimbus health gmbh

pharmaceutical company Dr. Reddy's Laboratories Ltd. RDY has entered into a definitive agreement to acq...

February 4, 2022, 7:37 am

Nyse-listed pharma co. dr. reddy's to acquire german medical cannabis firm nimbus health gmbh

pharmaceutical company Dr. Reddy's Laboratories Ltd. RDY has entered into a definitive agreement to acq...

February 4, 2022, 7:37 am

Regeneron shares up premarket after q4 revenue doubles and blows past estimates

Regeneron pharmaceuticals Inc. shares REGN, -0.35% rose 1.8% in premarket trade Friday, after the compa...

February 4, 2022, 6:41 am

Regeneron shares up premarket after q4 revenue doubles and blows past estimates

Regeneron pharmaceuticals Inc. shares REGN, -0.35% rose 1.8% in premarket trade Friday, after the compa...

February 4, 2022, 6:41 am

Regeneron shares up premarket after q4 revenue doubles and blows past estimates

Regeneron pharmaceuticals Inc. shares REGN, -0.35% rose 1.8% in premarket trade Friday, after the compa...

February 4, 2022, 6:41 am

Regeneron quarterly profit nearly doubles on robust sales of covid-19 therapy

Regeneron pharmaceuticals quarterly profit nearly doubled on Thursday, on strong sales of its COVID-19 ...

February 4, 2022, 6:38 am


Search within

Pages Search Results: